# WAVE6 A9 Task Analysis

## Task Analysis

**Task:** Implement `PR-A9` as a bounded Wave 6 docs-only evidence slice for
scientific reliability publication on the existing product-AI lane.

**Domain(s):** AI/ML | Architecture | Security | Documentation | Multiple

**Complexity:** Complex

**Priority:** P1

- **Priority track (P0-A / P0-B / P1):** P1

**Expected Outcome:** A narrow A9 lane publishes one canonical evidence packet
for current AI reliability proof without widening runtime scope. The packet
must rely on the governed offline replay contract, deterministic test surface,
and shipped runtime seams, while keeping all medical, production, and public
trust claims bounded.

**Invariants Affected:**
- [ ] One BMI Engine
- [x] Thin HTTP Adapter Policy
- [x] Layer Separation
- [x] Contract-First
- [x] Other: bounded Wave 6 product-AI docs/evidence rail

**Risks:**
1. Publication wording can outrun reproducible proof and imply production,
   clinical, or generalized scientific validation; mitigate by treating the
   offline replay contract as the only canonical evidence surface.
2. Analysis/insight prose can be misused as benchmark evidence; mitigate by
   citing those docs as background only and anchoring proof to the replay
   contract, tests, CLI, and local reproducibility path.
3. The backlog wording is broader than the current governed proof surface and
   can accidentally imply recursive execution is a canonical validated-evidence
   write path; mitigate by explicitly documenting that recursive execution is
   not the canonical validated-evidence path in this lane.
4. The local replay artifact lives under ignored `artifacts/`; mitigate by
   summarizing the metrics in a checked-in audit packet and adding exact
   reproducibility commands instead of relying on the local file alone.

**Proposed Approach:**
1. Freeze a dedicated A9 packet and task-analysis doc from live `HEAD` truth,
   not from older roadmap prose.
2. Re-run the deterministic replay test and CLI so the lane is grounded in
   current local evidence.
3. Publish one canonical audit packet with corpus bounds, per-arm metrics,
   publishable claims, forbidden claims, and trust boundaries.
4. Reconcile `BACKLOG_LEDGER.md` and the epic pipeline so both describe the
   same bounded docs-only evidence lane.
5. Keep all runtime, OpenAPI, response-shape, and verification-contract changes
   out of scope.

**Evidence / Current-head anchors:**
- A9 lane definition and backlog owner:
  `docs/roadmap/PulsePlate_RAG_LLM_Karpathy_Epic_Pipeline.md:493-506`,
  `docs/roadmap/BACKLOG_LEDGER.md:2945-2960`
- Canonical offline replay contract:
  `docs/orchestration/contracts/LOGIC_PHILOSOPHY_REPLAY_EVAL_CONTRACT.md:1-77`
- Deterministic replay test and artifact-path guard:
  `tests/test_logic_philosophy_replay_eval.py:153-241`
- Replay evaluator + result-path restriction:
  `scripts/orchestration/logic_philosophy_replay_eval.py:147-240`
- Fail-closed replay/negative-control validation:
  `scripts/orchestration/logic_philosophy_replay_contract.py:13-231`
- Shipped runtime anchors that can be referenced as implementation seams only:
  `core/ai/insight_runtime.py:68-80`,
  `core/insight/philosophical_runtime.py:192-216`,
  `core/verification/contracts.py:16-38`,
  `core/verification/registry.py:256-286`,
  `core/rag/orchestration.py:30-73`

**Agent Assignment:**
- **Primary:** `agent-coordinator` - owns scope, role order, synthesis, and DoD.
- **Secondary:** `data-scientist-agent` - locks publishable metrics, evidence
  framing, and claim boundaries.
- **Secondary:** `architecture-specialist` - binds claims to shipped runtime
  seams and prevents proof drift into design prose.
- **Secondary:** `backend-engineer` - verifies repo-truth anchors and confirms
  no non-doc changes are required.
- **Secondary:** `security-auditor` - enforces wellness-safe wording,
  non-medical disclaimers, and trust-surface guardrails.
- **Secondary:** `qa-engineer-agent` - defines the narrow validation bundle.
- **Secondary:** `bug-hunter` - mandatory final defect and scope-drift pass.

**Constraints:**
- Docs-only lane: no `core/*`, `app/*`, `legacy_app.py`, `app/routers/*`, or
  OpenAPI/DTO/public response changes.
- No semantic cache, Redis/GPTCache, GraphRAG, ContextManifest, or new runtime
  benchmark harness work.
- No claim that recursive execution is the canonical validated-evidence write
  path.
- No public `VerificationBundle` or verification-artifact claims.
- No production, latency, cost, clinical-efficacy, or health-outcome claims.
- Every published rate must carry corpus counts: `n=3` replay cases and `n=3`
  known-good controls.

---

**Analysis by:** agent-coordinator
**Date:** 2026-04-23
